The present invention provides compounds of Formula (I) as inhibitors of LMP7 for the treatment of autoimmune and inflammatory diseases.
本发明提供了化合物(I)的公式,作为LMP7的抑制剂,用于治疗自身免疫和炎症性疾病。
US9688702B2
申请人:——
公开号:US9688702B2
公开(公告)日:2017-06-27
[EN] NOVEL PEPTIDOMIMETIC NS3-SERINE PROTEASE INHIBITORS OF HEPATITIS C VIRUS<br/>[FR] NOUVEAUX INHIBITEURS PEPTIDOMIMETIQUES DE LA SERINE PROTEASE NS3 DU VIRUS DE L'HEPATITE C
申请人:SCHERING CORP
公开号:WO2005021584A2
公开(公告)日:2005-03-10
The present application discloses a compound, or enantiomers, stereoisomers, rotamers, tautomers or racemates of said compound, or pharmaceutically acceptable salts or solvates of said compound, said compound having the general structure shown in Formula (1): useful in the treatment or prevention or amelioration of one or more symptoms of hepatitis C.
Organocatalytic C−H Functionalization of Simple Alkanes
作者:Fen Su、Fengfei Lu、Kun Tang、Xiaokang Lv、Zhongfu Luo、Fengrui Che、Hongyan Long、Xingxing Wu、Yonggui Robin Chi
DOI:10.1002/anie.202310072
日期:2023.11.6
functionalization/acylation of strong aliphatic C(sp3)-H bonds is disclosed via an N-heterocyclic carbene (NHC)-catalyzed dehydrogenative coupling of aldehydes with simple alkanes. The inert aliphatic C−H bonds are efficiently cleaved through intermolecular hydrogen atom transfer, providing an alternative organocatalytic approach for alkane C−H functionalization under transition metal- and light free